Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2020-10-14 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 30th September, 2020 received form M/s ....
Regulatory Filings
2020-10-14 English
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (120 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report title, regulatory references, or any descriptive text. Given the lack of content, this cannot be classified as a full report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or empty filings.
2020-10-14 English
We wish to inform you that our existing RTA Agent M/s Sharex Dynamic India Pvt Ltd has been merged with M/s Link IntimePvt Ltd whose address and Contact details are as under; Link IntimePvt Ltd ....
Regulatory Filings
2020-10-14 English
Updates
Regulatory Filings
2020-09-29 English
We are in receipt of SEBI Adjudicating Order dated 28th September, 2020 which is received by us today at 03.20 P.M. pertaining to imposing of penalty u/s 23E of SCRA amounting to Rs. ....
Regulatory Filings
2020-09-29 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (541 characters) and contains no substantive financial data, analysis, or detailed reporting. It appears to be a brief notice or header information related to stock exchange listings or trading details, with no indication of a full report or detailed announcement. There are no references to financial results, management changes, voting results, or other specific report content. Given the brevity and lack of detailed content, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2020-09-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.